Healthcare - Biotechnology - NASDAQ - US
$ 8.78
-3.41 %
$ 600 M
Market Cap
-1.53
P/E
Price Target
Average
156.26%
Revenue Forecast
Estimate
477.21%
EBIT
Estimate
47.35%
Net Income
Estimate
24.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phathom Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for PHAT of $22.5 , with forecasts ranging from a low of $12 to a high of $28 .
PHAT Lowest Price Target
Wall Street Target
12 USD
36.67%
PHAT Average Price Target
Wall Street Target
22.5 USD
156.26%
PHAT Highest Price Target
Wall Street Target
28 USD
218.91%
REVENUE FORECAST
Revenue Forecast Chart PHAT
EBIT FORECAST
EBIT Forecast Chart PHAT
NET INCOME FORECAST
Net Income Chart PHAT